PHVSPharvaris N.V.
36.27USDMkt Cap: 2.55B $P/E: —3d ago
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The com…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.55B $
Enterprise Value2.23B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-175.70M $
Revenue/Share—
Last Price36.27 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees148
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINNL00150005Y4
Valuation
P/E (Trailing)—
P/E (Forward)-11.73
PEG—
EV/EBITDA-12.23
EV/Revenue—
P/S—
P/B7.34
EPS (TTM)-3.02
EPS (Forward)-3.10
52W Range
36.1317% of range36.93
52W High36.93 USD
52W Low36.13 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-64.77%
ROA-58.28%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-137.07M $
CapEx (TTM)164.62K $
FCF Margin—
FCF Yield-3.55%
Net Debt-317.61M $
Net Debt/EBITDA1.74
Balance Sheet
Debt/Equity0.00
Current Ratio11.94
Quick Ratio11.82
Book Value/Sh4.960 USD
Cash/Share4.534 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)49.17 USD
Upside (mean)+35.6%
Target Range38.48 USD – 75.96 USD
$38.48+35.6% to mean$75.96
# Analysts14
Ownership
Shares Out.70.20M
Float43.70M
Insiders6.08%
Institutions92.66%
Short Interest
Short Ratio2.4d
Short % Float2.08%
Short % Out.1.71%
Shares Short1.19M
Short (prev mo.)985.97K
Technical
SMA 5033.90 (+7.0%)
SMA 20028.76 (+26.1%)
Beta-2.33
S&P 52W Chg21.00%
Avg Vol (30d)513.30K
Avg Vol (10d)780.87K
Technical Indicators
RSI (14)58.3
MACD0.6760
MACD Signal0.4862
MACD Hist.+0.1898
BB Upper37.18 USD
BB Middle34.54 USD
BB Lower31.91 USD
BB Width15.23%
ATR (14)1.678 USD
Vol Ratio (20d)0.90x